Beta-interferon money better spent elsewhere, say neurologists
Funding for beta-interferon would be better spent on other ways of improving quality of life for patients with secondary progressive multiple sclerosis, says a group of Scottish researchers. “Realistically, far more benefit would be obtained from directing funds into improved supportive care,&…